Key result
Higher systolic blood pressure variability is linked to ~24% higher odds of in-hospital MACE after AMI.
Cohort (n=441)
No
Both short-term and mid-term systolic blood pressure variability independently predict adverse in-hospital outcomes, including mortality and MACE, in patients hospitalized with acute myocardial infarction.
Greater mid-term BP variability was associated with in-hospital MACE after AMI; hypothesis-generating for risk stratification and requires prospective validation.
Background Blood pressure variability (BPV) is increasingly recognized as a prognostic marker in cardiovascular disease. However, the combined impact of short-term and mid-term BPV on acute, in-hospital outcomes following acute myocardial infarction (AMI) remains insufficiently characterized. Methods In this prospective, single-center cohort study, both short-term and mid-term BPV were evaluated in patients hospitalized with AMI. Short-term BPV was assessed using average real variability (ARV) derived from 24-hour ambulatory blood pressure monitoring (ABPM), while mid-term BPV was calculated as the standard deviation (SD) of daily in-hospital blood pressure measurements. Associations with in-hospital outcomes, including mortality and major adverse cardiovascular events (MACE), were analyzed using multivariable logistic regression models. Results Among 441 AMI patients, increased mid-term systolic BPV (SBP-SD) was strongly associated with in-hospital MACE, with each 1 mmHg increase conferring a 24% higher risk (OR 1.24, 95% CI 1.17–1.31). Patients in the highest quartile (Q4) of SBP-SD demonstrated a markedly elevated risk of in-hospital MACE compared with Q1 (OR 28.89, 95% CI 8.58–97.28). Short-term systolic BPV assessed by ABPM (SBP-ARV) independently predicted in-hospital mortality (OR 1.58, 95% CI 1.21–2.07) and MACE (OR 1.35, 95% CI 1.23–1.48). Elevated diastolic BP-ARV was significantly associated with in-hospital myocardial infarction, malignant arrhythmias, and cardiogenic shock. All associations remained significant after adjustment for mean blood pressure and established clinical risk factors. Conclusion Both short-term and mid-term systolic BPV independently and synergistically predict adverse in-hospital outcomes in AMI patients. BPV assessment during hospitalization may enhance early risk stratification beyond conventional blood pressure metrics.
No takes yet. Share an insight, caveat, or question.
Κωνσταντίνου et al. (2026) conducted a cohort in Acute myocardial infarction (AMI) (n=441). Short- and mid-term blood pressure variability (SBP-SD and SBP-ARV) vs. Lower blood pressure variability (e.g., lowest quartile Q1 of SBP-SD or per 1 mmHg increase) was evaluated on In-hospital major adverse cardiovascular events (MACE) and mortality (OR 1.24, 95% CI 1.17-1.31). Increased mid-term (OR 1.24; 95% CI 1.17-1.31) and short-term (OR 1.35; 95% CI 1.23-1.48) systolic blood pressure variability independently predicted in-hospital MACE in AMI patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: